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Abstract
The formation of hydrate plugs in oil and gas pipelines is a serious industrial problem and recently there has been an
increased interest in the use of alternative hydrate inhibitors as substitutes for thermodynamic inhibitors like methanol. We
show here that antifreeze proteins (AFPs) possess the ability to modify structure II (sII) tetrahydrofuran (THF) hydrate crystal
morphologies by adhering to the hydrate surface and inhibiting growth in a similar fashion to the kinetic inhibitor poly-N-
vinylpyrrolidone (PVP). The effects of AFPs on the formation and growth rate of high-pressure sII gas mix hydrate
demonstrated that AFPs are superior hydrate inhibitors compared to PVP. These results indicate that AFPs may be suitable
for the study of new inhibitor systems and represent an important step towards the development of biologically-based
hydrate inhibitors.
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Introduction
Gas hydrates, or clathrates, are ice-like compounds that form
when hydrocarbon-based guest molecules are trapped in hydro-
gen-bonded water cages that form under high pressures and low
temperatures [1]. Natural gas hydrates most commonly exist as
one of two structures. Small guest molecules such as methane tend
to form structure I (sI) hydrates while larger guests like propane
form structure II (sII) hydrates [2]. In the laboratory, gas hydrates
are conveniently modeled using tetrahydrofuran (THF) which is
enclathrated at atmospheric pressures [3]. THF hydrate forms
cubic sII clathrates, similar to the hydrates that form in pipelines
during oil and gas production [4].
Recently, the petroleum industry has been moving into deeper
waters which present prime conditions for hydrate growth.
Hydrate plugs impede oil and gas flow, resulting in equipment
damage as well as hazardous working conditions that can even
result in blowouts [5]. Thermodynamic inhibitors such as
methanol are one of the most common practical means of
controlling hydrate formation [6]. However, as a result of the high
costs, flammability and environmental toxicity associated with
such inhibitors, there has been a shift towards the less toxic and
sometimes cheaper alternative kinetic hydrate inhibitors, which
delay nucleation and interfere with crystal growth, as well as
antiagglomerants, which act to prevent hydrates from aggregating
into larger masses [7,8].
These concerns have prompted us to investigate the potential
inhibitory effects of antifreeze proteins (AFPs) on hydrates. AFPs
are a diverse class of proteins that were first identified in fish
during the 1950s and have since been found in cold-adapted
bacteria, plants and insects [9–13]. Despite differences in
structure, they have the common ability to adsorb to ice using
specific ice-binding faces. AFPs lower the freezing point of water as
a result of increased local curvature of growing ice around the
adsorbed protein, resulting in a difference between the freezing
and melting points, a phenomenon known as thermal hysteresis
(TH) [13].
We have previously proposed AFPs as alternative hydrate
inhibitors [14–15]. Here we visualize fluorescently-tagged AFPs
and characterize the effects of these proteins on THF hydrate
crystals. We also determine the inhibitory effects of these AFPs on
the gas consumption and growth rates of sII natural gas hydrate as




The AFP cloned from the perennial grass, Lolium perenne (Lp),
has a low TH while the ocean pout fish Type III AFP is more
active [9,11]. Sequences encoding these AFPs, with or without a
green fluorescent protein (GFP) label, were expressed in E. coli
grown in a bioreactor. Yields were comparable for all recombinant
proteins, although optimization of AFP production depended on a
variety of conditions including total volume of growth media, level
of dissolved oxygen (DO) or OD600 at isopropyl b-D-1-
thiogalactopyranoside (IPTG) induction as well as temperature
during the induction period. Although most of these parameters
were kept as constant as possible, it was generally found that lower
induction temperatures (#20uC), yielded the highest amounts of
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ranged from 180 to 260 mg. Purified recombinant proteins were
seen as single bands on a 12% SDS-PAGE gel (Fig. 1). TH values
for the AFPs were in the expected ranges at 0.10 (68.5610
23)uC
for LpAFP-GFP, 0.48 (62.8610
22)uC for Type III AFP-GFP and
0.43 (62.8610
22)uC for Type III AFP. Control GFP showed no
TH. All proteins were tested at ,4 mg/ml.
Recombinant GFP-Labeled Proteins and Polycrystalline
THF Hydrate
Polycrystalline THF hydrate crystals grown in the presence of
GFP-tagged AFPs were obviously fluorescent green under UV
illumination (Fig. 2). Conversely, when hydrate was grown in the
presence of recombinant GFP alone, the hydrates were uniformly
dark. In an effort to quantify the adsorption, the hydrates were
melted and assayed for adsorbed protein (mmoles of recombinant
protein per gram of crystal, Fig. 3). For both purified LpAFP-GFP
and Type III AFP-GFP fusion proteins, there was a linear
correlation between the amount of protein adsorbed into the
growing THF hydrate and the concentration of the protein in the
THF solution. At lower concentrations (2 and 4 mM) more Type
III AFP-GFP appeared to bind than LpAFP-GFP. At higher
concentrations (8 and 16 mM) more LpAFP-GFP adsorbed, to an
average of 42% more, than Type III AFP. All differences between
the two AFP-GFPs were statistically significant. In contrast, no
adsorption of GFP was detected in the crystals at any
concentration, with the exception of 2 mM, where an average of
7.9610
25 mmoles/g-crystal was detected. At all other concentra-
tions, differences in the amounts of GFP bound compared to the
two AFP-GFPs were statistically significant.
AFPs and Single THF Hydrate Crystals
Since the fusion proteins adsorbed to polycrystalline THF
hydrate, single THF hydrate crystals were slowly grown at low
supercooling (3uC) to observe if the presence of the proteins could
change crystal morphology. With no proteins, or in the presence of
low to moderate concentrations of GFP (Fig. 4A and B), crystals
exhibited a cubic octahedral shape that is characteristic of THF
hydrate at these conditions [16]. The {111} planes were clearly
defined and there were no apparent modifications to crystal shape.
In striking contrast, when single crystals were grown under the
same conditions, but in the presence of recombinant AFPs, they
exhibited hopper-like or skeletal morphologies (Fig. 4C–G), indicat-
ing interference in normal crystal growth habit [17]. At all but the
lowest concentration of LpAFP-GFP, depressions were observed on
the interior {111} faces. Similar morphologies were seen in crystals
grown in solutions of all but the lowest concentration (15 mg/ml, or
0.472 mM) of Type III AFP-GFP. Interestingly, only the non-GFP
tagged Type III AFP displayed clear skeletal shaping at the lowest
concentration (15 mg/ml, or 2.2 mM ) .I tw a sn o tp o s s i b l et ot e s tt h i s
protein at higher concentrations since it precipitated easily in the
THF solution. As indicated, recombinant GFP did not appear to
alter crystal morphology until tested at very high concentrations (100
and 200 mg/ml, or 4 and 8 mM) and even then showed only one to
two shallow face depressions. When the crystals grown in AFP-GFP
solutions were observed under UV light, it appeared that the protein
had adsorbed uniformly throughout the entire cubic crystal and at
every face (Fig. 4F and G). Consistent with the morphological
observations, there was no evidence of GFP adsorption under UV
light at the low or moderate concentrations used.
In order to compare the effect of a known sII inhibitor on the
growth habit of single THF hydrate crystals, crystals were grown
in solutions containing poly-N-vinylpyrrolidone (PVP). In all but
the lowest concentration of PVP, single crystals were hopper-like
and similar to those grown in the presence of AFPs, with the
depressions on the {111} faces becoming more pronounced as the
concentration of PVP increased (Fig. 4H). It should be noted that
all these crystals were grown slowly at temperatures just below the
THF hydrate crystallization point. When single crystals were
grown at higher driving force, in supercooled conditions at 0uC
(Fig. 4I) or at 21.5uC, they exhibited a skeletal morphology like
crystals grown in AFPs and PVP.
AFPs and Gas Hydrates
Gas hydrates were formed under high driving force using a
natural gas (methane/ethane/propane) mixture so as to produce sII
hydrate (Fig. 5). Both average moles of gas consumed (nGas) and
average consumption rates followed identical patterns. Because the
control samples, without additives, stopped growing at ,25 h (1
500 min), this time was selected as a cutoff point to compare gas
consumption and growth rates. On average, the highest level of
i n h i b i t i o nw a ss e e ni nt h ep r e s e n c eo fT y p eI I IA F P( w i t hn oG F P
fusion protein). In the presence of this protein, hydrate formation
consumed 6.0 mmol of gas and showed a decrease in growth rate by
18% (a mean of 4.0610
26 nGas/min) compared to control samples
which consumed the highest amount of gas at 7.4 mmol and
showed the fastest growth rates (4.9610
26 nGas/min). LpAFP-
GFP and Type III AFP-GFP demonstrated modestly lower gas
consumption (6.6 mmol,gas consumption,6.4 mmol) and de-
creased growth rates of 10 and 13%, respectively
(4.4610
26 nGas/min,growth rate,4.3610
26 nGas/min). In con-
trast, the GFP and PVP samples showed the highest levels of gas
consumption, except for controls, equally at 6.9 mmol, with a fast
growth rate (4.6610
26 nGas/min for both), a 7.1% decrease,
compared to the controls.
Figure 1. Purification of recombinant proteins. Typical 12% SDS-
PAGE analysis of recombinant His-tagged bioreactor-produced proteins
including LpAFP-GFP (A), Type III AFP-GFP (B), GFP (C) and Type III AFP
(D), purified using Co
2+-agarose affinity chromatography. Average TH
values are shown below.
doi:10.1371/journal.pone.0008953.g001
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The observation that the polycrystalline THF hydrates were
strikingly fluorescent after being grown in the presence of
recombinant AFP-GFPs (Fig. 2) is irrefutable evidence that these
proteins adsorb to sII hydrates. Further substantiation is provided
by the morphological changes on single hydrate crystals mediated
by these same proteins (Fig. 4). This might not have been predicted
a priori because although hydrates have an ice-like appearance,
their structure is markedly different. Under common conditions,
water freezes into hexagonal ice (Ih), taking the form of a
hexagonal prism with two basal faces and six rectangular prism
Figure 2. Adsorption of AFPs on THF hydrate. Representative THF hydrate polycrystals fluoresce green under UV light after being grown in
solutions containing Type III AFP-GFP (left) and LpAFP-GFP (center). THF hydrate crystals grown in GFP control solutions (right) displayed no
fluorescence. Sample diameters were 3–3.5 cm.
doi:10.1371/journal.pone.0008953.g002
Figure 3. Levels of AFP adsorbed into THF hydrate. Differences in the average mmoles of protein adsorbed per gram of THF hydrate crystal
(mmoles/g-crystal) between LpAFP-GFP (horizontal lines), Type III AFP-GFP (vertical lines) and GFP (solid) are plotted as a function of protein
concentration (mM). Bars indicate standard deviation. Statistical significance between each data group is indicated by letters A–C, where identical
letters indicate no statistical difference.
doi:10.1371/journal.pone.0008953.g003
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Type III AFP-GFP) have been shown to bind to the ice basal
planes, with the low activity LpAFP binding to the prism planes
[19,20]. Thus, evolutionary forces have shaped these AFPs so that
they fit securely to these ice surfaces making it more energetically
expensive for water molecules to join the growing ice lattice. In
contrast, sII hydrates are octahedral with a symmetrical cubic
structure and therefore, although similarly flat to ice, present
geometrically-distinct, but uniform surfaces for AFP adsorption.
There was no preference by AFPs for any of the 8 identical
{111} hydrate faces (Fig. 4F and G), and indeed the resulting
hopper-like crystals were similar to those generated in the presence
of the commercial kinetic inhibitor, PVP (Fig. 4H). This skeletal
growth is believed to occur as a result of the more efficient
dissipation of the heat of crystallization on the crystal edges, as
opposed to the interior planes, as has been previously described
[16]. At higher driving forces (4.4 and 5.9uC subcooling) we
demonstrated that these faces were the slowest growing regions of
the crystal (Fig. 4I). Since GFP alone did not adsorb to the THF
hydrate (Figs. 2–4), we postulate that the inhibition of hydrate
growth by AFPs is mediated by the structure of the proteins, and
these become adsorbed into the crystal below the equilibrium
growth point. Previously, another control protein, cytochrome C,
was not seen to effect THF hydrate growth [15]. Curiously
perhaps, the plant LpAFP-GFP with low TH activity towards ice
but with a higher ice recrystallization inhibition activity than some
other AFPs [20], showed 1.6 fold more absorption onto
polycrystalline THF hydrate (at least at the higher concentrations)
than the moderately ice-active Type III AFP-GFP. However, Type
III without the GFP tag appeared to have superior hydrate-
shaping, but its hydrate-binding affinity could not be quantified
due its vulnerability to THF denaturation at higher concentrations.
These experiments were all conducted with the model THF
hydrate, and thus we thought it important to determine if these
recombinant proteins could also show inhibition toward natural
gas hydrates. Although some fish AFPs and insect AFPs have
Figure 4. Single THF hydrate crystals. Single crystals grown in solutions of THF/water (A) and 200 mg/ml GFP (B) show no major changes in
morphology. Crystals grown in solutions containing 200 mg/ml (30 mM) Type III AFP-GFP (C), 200 mg/ml (4.9 mM) LpAFP-GFP (D) and 15 mg/ml (2.2 mM)
Type III AFP (E) show skeletal growth. Crystals with adsorbed Type III AFP-GFP (100 mg/ml; 3.1 mM) (F) and LpAFP-GFP (100 mg/ml; 2.4 mM) (G) show skeletal
growth and fluoresce under UV light. Skeletal crystals were grown in 200 mg/ml (20 mM) PVP (H). Crystals (A–H) were grown at 3uC. Control crystals grown
in THF/water at high driving force (0uC) show skeletal growth (I). All experiments were done in triplicate and have 4.5–5 cm crystal diameters.
doi:10.1371/journal.pone.0008953.g004
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GFP fusions used here have never been tested, nor have the tested
hydrates been formed using a gas mixture that would be found in a
high-pressure oil and gas pipeline [22]. Conditions in pipelines can
vary, but deep sea lines are generally at 4uCa n d$1 000 PSI
(6.9610
4 mbar) [7], an environment that we approximated here.
These parameters did not seem to have deleterious effects on the
proteins because even when the gas hydrates were thawed and the
proteins used a second time, inhibition activity was still observed
(not shown). All of the investigated AFPs showed hydrate inhibition
as determined by gas uptake assessments. Similar to the
observations on the single THF crystals, LpAFP-GFP and Type
III AFP-GFP showed hydrate inhibition that was modestly higher
than the chemical inhibitor PVP. GFP showed little inhibition,
possibly only due to a colligative effect since, as indicated, no
incorporation into THF hydrate was seen. Of the additives tested,
Type III AFP was demonstrably superior with an overall 18%
decrease in gas hydrate formation, validating again the observa-
tions made with this protein on THF single hydrate crystals.
In conclusion, we have demonstrated for the first time that AFPs
irreversibly adsorb to sII hydrate surfaces and we speculate that
they act as inhibitors by binding to the {111} faces of the these
symmetrical cubic crystals. We further consider that the identified
ice-binding residues of these proteins may not be identical to the
residues that interact with the hydrate surface, but the way is now
clear for such an investigation. In addition, these experiments have
established that AFPs are suitable models for understanding
hydrate-inhibitor reactions and offer the prospect that these
proteins, or their modified cognates, will be useful as new and
more effective biologically-based hydrate inhibitors.
Materials and Methods
Bacterial Strains and THF Solutions
Sequences encoding the AFPs were expressed in E. coli BL21
cells. The plasmids used included the pET-24 vector (Novagen) for
the expression of Type III AFP (7 kDa) and LpAFP-GFP
(41 kDa), and pET-20b (Novagen) for Type III AFP-GFP
(32 kDa). A plasmid encoding a control GFP (25 kDa) without
an AFP sequence, was made by the amplification of GFP from the
pET-20 vector expressing the Type III AFP-GFP sequence using
primers with a 59-NdeI site and a 39-HindIII site. The amplified
GFP was then inserted into a pET24a vector between its NdeI/
HindIII sites, followed by subsequent transformation of BL21 cells.
The insert was verified by sequencing. All of the recombinant
proteins were tagged with a poly(His)6 sequence located on the C-
terminal of the expressed proteins to facilitate purification.
THF ($99.5%, Sigma-Aldrich, St. Louis, MO, USA) was
mixed with distilled water or water containing solutions of proteins
or other additives, at a 1:15 molar ratio or 1: 3.34 (v/v) as
previously described [3]. The observed crystallization temperature
was the same as published values (#4.4uC) [15].
Bioreactor: Production and Purification
Recombinant E. coli BL21 cells were grown in a New Brunswick
Bio-Flow 110 bioreactor (Edison, NJ, USA) using Luria-Bertani (LB)
media enriched with 5 g/L yeast extract, 6 g/L glucose, 12 g/L
Na2HPO4,6g / LK 2HPO4,2g / LN H 4C l ,0 . 0 2 2g / LC a C l 2 and
0.482 g/L MgSO4 at 37uC, pH 7, 650 RPM agitation and 4 L/min
air flow, until the culture reached OD600=8 or the DO levels were at
a minimum (0–20%). The culture temperature was then decreased to
20uC, and recombinant protein expression was induced with 1 mM
IPTG for 16 h. The cells were harvested by centrifugation (6 0006g,
4uC, for 20 min) and resuspended in cold lysis buffer (20 mM Tris,
500 mM NaCl, pH 7, containing an EDTA-free protease inhibitor
cocktail (Mini pills; Roche, Manheim, Germany).
The pelleted cells were then lysed using a Branson sonicator for
4 min with 1 min cooling on ice and centrifuged (16 0006g, 4uC
for 40 min) to remove solid cell debris. The supernatant was then
mixed with cobalt-based agarose Talon Metal Affinity Resin (BD
Bioscience, Mountain View, CA, USA) and incubated for 1.5 h at
4uC with mild shaking, allowing the poly(His)-tagged proteins to
bind to the resin. The supernatant/resin mixture was then loaded
onto a 100 ml column and the resin was washed twice with wash
buffer (20 mM Tris, 500 mM NaCl, pH 7), once with wash buffer
containing 5 mM imidazole, followed by 10 mM imidazole and
Figure 5. Pressure summary of sII methane/ethane/propane gas hydrate with 0.1 mM additives. Pressure trends plotted against time for
Type III AFP, Type III AFP-GFP, LpAFP-GFP, GFP, PVP and control water samples. Absolute pressure drops are proportional to the quantity of moles of
gas consumed. Experiments were done in duplicate.
doi:10.1371/journal.pone.0008953.g005
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was visualized on a 12% SDS-PAGE gel stained with Coomassie
Brilliant Blue R-250 to assess purity. Protein concentration was
determined using dye-binding via bicinchurinic acid assay (BCA
Protein Assay Kit; Pierce, Rockford, IL, USA). Thermal hysteresis
(TH) was measured as previously described [23] with a nanolitre
osmometer at protein concentrations of approximately 4 mg/ml
(Clifton Technical Physics, Hartford, NY, USA).
Polycrystalline THF Hydrate
Polycrystalline THF hydrate was grown on a hollow brass finger
connected to a temperature-programmable 1197P water bath
(VWR International, Mississauga, ON) filled with a water/
ethylene glycol mixture (at 3:1 v/v). A solution of THF/water
(1:3.34, v/v; 80 ml) was cooled to 4uC and poured into a 100 ml
glass beaker, placed in an insulated box. The cooled brass finger
(2.5uC) was submerged into the THF/water solution, which was
stirred with a magnetic stir bar. To expedite hydrate formation, a
small piece of THF hydrate crystal was added into the solution,
which helped nucleate a thin layer of hydrate on the surface of the
brass finger, a process known as seeding. When the THF hydrate
uniformly covered the finger, the beaker was removed and
replaced with another containing 80 ml of the test solution, and
sealed with parafilm to prevent the evaporation of THF.
Triplicate test solutions of consisted of THF/water (1:3.34, v/v;
80 ml) containing 2 mM, 4 mM, 8 mM and 16 mM of purified
recombinant LpAFP-GFP, Type III AFP-GFP and GFP. THF
polycrystals were grown for 8 h with the ethylene/glycol bath set
to an initial temperature of 0uC and a final temperature of
26.5uC, with a 0.5uC drop every 30 min. The temperature of the
THF/water/protein solution surrounding the growing crystal
remained at approximately 4.9uC for the duration of the
experiment. At the conclusion of the growth period, the beaker
was removed and the adhered polycrystal was wrapped in
aluminum foil and placed in ice to prevent melting. The bath
temperature was then increased to 5.5uC, heating the brass finger
and allowing the crystal to be collected.
After washing the crystal with 30 ml of distilled water (,4uC) to
remove any residual solution, it was weighed and examined under
UV light (midpoint wavelength =302 nm) at 4uC and photo-
graphed. After melting the polycrystals at room temperature, the
solution was concentrated to 2 ml with a 15 ml concentrating tube
(Millipore, Billevica, MA, USA), and the protein concentration
was determined as above. The amount of recombinant protein
adsorbed per gram of hydrate crystal (denoted as mol/gcrystal) was
calculated and a Tukey honestly significant difference (HSD) test
was used for statistical comparisons (a=0.05, q*=3.07).
Single Crystal THF Hydrate
Single THF hydrate crystals were formed at 3uC( 1 . 4 uC
supercooling) by placing a glass Pasteur pipette, held in place by a
central hole punched through a rubber stopper, into a beaker sealed
with parafilm containing 80 ml THF solution. Recombinant AFPs,
GFP or a commercial hydrate inhibitor, PVP (MW 10 000; Sigma-
Aldrich, St. Louis, MO, USA) were added at 15 mg/ml (correspond-
ing to 2.2 mM Type III AFP, 0.47 mM Type III AFP-GFP, 0.37 mM
LpAFP-GFP, 0.60 mMG F Pa n d1 . 5mM PVP from here on in),
50 mg/ml (corresponding to molar concentrations of 7.4 mM,
1.6 mM, 1.2 mM, 2.0 mMa n d5 . 0mM), 100 mg/ml (corresponding
to molar concentrations of 15.0 mM, 3.1 mM, 2.4 mM, 4.0 mMa n d
10.0 mM) and 200 mg/ml (corresponding to molar concentrations of
30.0 mM, 6.3 mM, 4.9 mM, 8.0 mM and 20.0 mM) to observe changes
in THF single crystal morphologies. The experiments were performed
using wt/vol as opposed to molar concentrations because previous
experiments using this technique were done in a similar fashion
[16,17]. In contrast to earlier studies [14,17], single crystals were
never transferred to inhibitor solutions, which can result in additional
nucleation sites. To determine the effects of high supercooling rates on
crystal structure, some crystals were grown at 0uCa n d21.5uC.
Crystal growth was initiated inside the pipette by nucleating the
solution with a supercooled copper wire placed in dry ice, as
described [17]. THF hydrate was formed down the pipette’s
decreasing diameter until a single, octahedral crystal emerged from
the tip. If more than one crystal was initiated, or the beaker was
jarred, the experiment was discontinued, as this resulted in
polycrystalline growth. The crystal was grown slowly for approxi-
mately 6 h, or until the crystal edges touched the beaker walls. When
complete, the crystal was removed from the solution and frozen at
220uC until photographed (Nikon, Coolpix S10).
sII Gas Hydrate
Recombinant proteins Type III AFP-GFP, LpAFP-GFP, Type
III AFP and GFP, as well as PVP were mixed at 0.1 mM
concentrations with 1 000 A ˚ pore diameter silica gel (Silicycle
Chemicals, St. Jean-Baptiste, QC) at a ratio of 1 to 1.3 (v/w)
respectively. The inclusion of the gel allowed more predictable and
consistent nucleation times [24]. It is composed of an organic form
of silicon and not amorphous silica, to which other AFPs have been
reported to adsorb [25]. Briefly, the silica sand/additive mix was
added into a stainless steel cell. After the sample system was
immersed into a water bath set to 25uC, the sample was purged
twice by a natural gas mix consisting of 2% propane, 5% ethane
and 93% methane (Linde Canada, Mississauga, ON) at approx-
imately 250 PSI (1.7610
4 mbar), and then was pressurized to 1000
PSI (6.9610
4 mbar) with the same gas mixture. Hydrate nucleation
was initiated by transferring the pressurized cell into another water
bath set to 0.5uC. Hydrate formation was monitored by a sudden
drop in pressure (recorded using an Omega DAQPRO-5300;
Fourier Systems, Fairfield, CT, USA). Moles of gas consumed
(nGas), indicating the amount of hydrate formed, were calculated as
previously described [26] with a minor modification.
nGas ~VP =zRT ðÞ 0{ VP =zRT ðÞ t
This relationship allows the determination of the difference
between moles of gas at time t=0 and the number of moles of gas at
time t,w h e r et h eVi st h ev o l u m eo ft h eg a sp h a s e ,o rt h ec e l l
volume minus the sample volume, P is pressure, R is the gas
constant, T is temperature and z is the compressibility factor,
calculated by Pitzer’s correlations [27] and assuming no change in
gas phase volume coincident with hydrate formation. Additionally,
the rate of change of gas consumption, denoted as nGas/min
(indicative of the rate of hydrate growth), was calculated by
determining the average of the slopes of all nGas data points
(slope = DnGas/ Dtime). Experiments were performed in duplicate.
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